Period Ending | Sep 30, 2011 | Jun 30, 2011 | Mar 31, 2011 | Dec 31, 2010 |
---|
Total Revenue
|
1,216,665
|
1,229,024
|
1,214,357
|
1,525,109
| Cost of Revenue | 359,276 | 371,155 | 377,462 | 557,687 | |
Gross Profit
|
857,389
|
857,869
|
836,895
|
967,422
| |
|
Operating Expenses |
|
Research Development | 254,958 | 246,513 | 243,067 | 277,822 |
|
Selling General and Administrative | 419,463 | 411,642 | 385,458 | 424,263 |
|
Non Recurring | (2,721) | 237 | 10,575 | 37,735 |
|
Others | 8,435 | 8,582 | 8,050 | 7,626 |
|
|
|
Total Operating Expenses | 680,135 | 666,974 | 647,150 | 747,446 | | |
Operating Income or Loss
|
177,254
|
190,895
|
189,745
|
219,976
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 18,046 | (5,666) | 5,027 | 7,602 |
|
Earnings Before Interest And Taxes | 195,300 | 185,229 | 194,772 | 227,578 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 195,300 | 185,229 | 194,772 | 227,578 |
|
Income Tax Expense | 55,731 | 55,629 | 52,120 | 17,142 |
|
Minority Interest | (5,053) | (1,530) | (1,840) | (5,927) |
|
|
|
Net Income From Continuing Ops | 293,291 | 236,972 | 222,992 | 312,020 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
293,291
|
236,972
|
222,992
|
312,020
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
293,291
|
236,972
|
222,992
|
312,020
|
|